Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AMYRIS, INC.AMRS · Entity 91367 | CHIEF LEGAL OFFICER- SECRETARY | September 02, 2022 | September 07, 2022 |
| AVITA Medical, Inc.RCEL · Entity 5905 | Chief Legal Officer | February 18, 2026 | February 19, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AMYRIS, INC.
Report date September 02, 2022 · Filed September 07, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 58,314 |
Reported balance
After 2022-09-02 transaction · row 1
1 source rowRow 1 · 2022-09-02 · Sale · Disposed 5,019 · Balance 58,314 F1: Shares sold to satisfy the Reporting Person's tax withholding obligation upon vesting of restricted stock units (RSUs) under RSU award granted on August 10, 2020. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares sold to satisfy the Reporting Person's tax withholding obligation upon vesting of restricted stock units (RSUs) under RSU award granted on August 10, 2020.
AVITA Medical, Inc.
Report date February 18, 2026 · Filed February 19, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 98,390 |
Reported balance
After 2026-02-18 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-02-18 · Grant · Acquired 98,390 · Balance 98,390 F1: Represents an award of restricted stock units (the "RSUs"), each RSU representing a contingent right to be issued one share of Common Stock of the Company (the "Common Stock"), that are subject to time-based vesting criteria. These RSUs vest in three equal annual installments beginning on the date 12 months following the grant date of February 18, 2026. F2: Includes unvested RSUs. |
| Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $4.31 · Expires 2036-02-18 | Direct | 145,060 |
Reported balance
After 2026-02-18 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-02-18 · Grant · Acquired 145,060 · Balance 145,060 F3: These Stock Options vest in three equal annual installments beginning the first anniversary of the grant date of February 18, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents an award of restricted stock units (the "RSUs"), each RSU representing a contingent right to be issued one share of Common Stock of the Company (the "Common Stock"), that are subject to time-based vesting criteria. These RSUs vest in three equal annual installments beginning on the date 12 months following the grant date of February 18, 2026.
F2: Includes unvested RSUs.
F3: These Stock Options vest in three equal annual installments beginning the first anniversary of the grant date of February 18, 2026.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 18, 2026 Filed Feb 19, 2026 16:30 UTC | AVITA Medical, Inc. RCEL · Entity 5905 | GrantStock Options (Right to Buy) · Derivative | 145,060 | $0.00 Strike: $4.31 | $0.00 |
DisclosureSEC source: 0001193125-26-059502 · ownership.xml · derivative · entry 2 KELSEY NICOLE · CIK 0001714653 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 145,060 Underlying: Common Stock · 145,060 shares Expires 2036-02-18 F3 · derivative.exercise_date: These Stock Options vest in three equal annual installments beginning the first anniversary of the grant date of February 18, 2026. Read SEC document |
| February 18, 2026 Filed Feb 19, 2026 16:30 UTC | AVITA Medical, Inc. RCEL · Entity 5905 | GrantCommon Stock | 98,390 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-059502 · ownership.xml · nonDerivative · entry 1 KELSEY NICOLE · CIK 0001714653 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 98,390 F1 · price: Represents an award of restricted stock units (the "RSUs"), each RSU representing a contingent right to be issued one share of Common Stock of the Company (the "Common Stock"), that are subject to time-based vesting criteria. These RSUs vest in three equal annual installments beginning on the date 12 months following the grant date of February 18, 2026. F2 · balance_after: Includes unvested RSUs. Read SEC document |
| January 21, 2025 Filed Jan 22, 2025 16:30 UTC | AVITA Medical, Inc. RCEL · Entity 5905 | GrantStock Options (Right to Buy) · Derivative | 65,000 | $0.00 Strike: $8.73 | $0.00 |
DisclosureSEC source: 0000950170-25-007793 · ownership.xml · derivative · entry 1 KELSEY NICOLE · CIK 0001714653 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,000 Underlying: Common Stock · 65,000 shares Expires 2034-01-21 F1 · derivative.exercise_date: These Stock Options vest in three equal annual installments beginning the first anniversary of the grant date. Read SEC document |
| September 02, 2022 Filed Sep 7, 2022 20:08 UTC | AMYRIS, INC. AMRS · Entity 91367 | SaleCommon Stock | 5,019 | $2.87 | $14,404.53 |
DisclosureSEC source: 0001365916-22-000113 · wf-form4_166259571543568.xml · nonDerivative · entry 1 KELSEY NICOLE · CIK 0001714653 · CHIEF LEGAL OFFICER- SECRETARY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,314 F1 · shares: Shares sold to satisfy the Reporting Person's tax withholding obligation upon vesting of restricted stock units (RSUs) under RSU award granted on August 10, 2020. Read SEC document |
| June 30, 2022 Filed Jul 1, 2022 16:45 UTC | AMYRIS, INC. AMRS · Entity 91367 | SaleCommon Stock | 94,033 | $1.80 | $169,419.26 |
DisclosureSEC source: 0001365916-22-000072 · wf-form4_165670832552138.xml · nonDerivative · entry 1 KELSEY NICOLE · CIK 0001714653 · CHIEF LEGAL OFFICER- SECRETARY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,333 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person as part of personal liquidity planning for tax purposes. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.765 to $1.84, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| June 02, 2022 Filed Jun 3, 2022 18:09 UTC | AMYRIS, INC. AMRS · Entity 91367 | SaleCommon Stock | 8,406 | $2.34 | $19,670.88 |
DisclosureSEC source: 0001365916-22-000056 · wf-form4_165429414765082.xml · nonDerivative · entry 1 KELSEY NICOLE · CIK 0001714653 · CHIEF LEGAL OFFICER- SECRETARY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 157,366 F1 · shares: Shares sold to satisfy the Reporting Person's tax withholding obligation upon vesting of restricted stock units (RSUs) under RSU award granted on May 24, 2021. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.34 to $2.36, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| May 23, 2022 Filed May 25, 2022 18:31 UTC | AMYRIS, INC. AMRS · Entity 91367 | GrantCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001365916-22-000047 · wf-form4_165351787967640.xml · nonDerivative · entry 1 KELSEY NICOLE · CIK 0001714653 · CHIEF LEGAL OFFICER- SECRETARY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165,772 F1 · shares: Represents a restricted stock unit award that vests in three (3) equal annual installments, with the first 1/3 of the units vesting on June 1, 2023. Read SEC document |
| September 02, 2021 Filed Sep 3, 2021 21:55 UTC | AMYRIS, INC. AMRS · Entity 91367 | SaleCommon Stock | 3,483 | $14.86 | $51,757.38 |
DisclosureSEC source: 0001365916-21-000094 · wf-form4_163072052949523.xml · nonDerivative · entry 1 KELSEY NICOLE · CIK 0001714653 · CHIEF LEGAL OFFICER- SECRETARY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 155,772 F1 · shares: Shares sold to satisfy the Reporting Person's tax withholding obligation upon vesting of restricted stock units (RSUs) under RSU award granted on August 10, 2020. Read SEC document |
| May 24, 2021 Filed May 26, 2021 20:27 UTC | AMYRIS, INC. AMRS · Entity 91367 | GrantStock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $13.39 | $0.00 |
DisclosureSEC source: 0001365916-21-000032 · wf-form4_162207525010580.xml · derivative · entry 2 KELSEY NICOLE · CIK 0001714653 · GENERAL COUNSEL AND SECRETARY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2031-05-24 F2 · derivative.exercise_date: The stock option vests as to 25% of the shares subject to the option on May 24, 2022, with the remainder vesting over the following three (3) years in equal monthly installments. Read SEC document |
| May 24, 2021 Filed May 26, 2021 20:27 UTC | AMYRIS, INC. AMRS · Entity 91367 | GrantCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001365916-21-000032 · wf-form4_162207525010580.xml · nonDerivative · entry 1 KELSEY NICOLE · CIK 0001714653 · GENERAL COUNSEL AND SECRETARY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 159,255 F1 · shares: Represents a restricted stock unit award that vests in three (3) equal annual installments, with the first 1/3 of the units vesting on June 1, 2022. Read SEC document |
| May 01, 2021 Filed May 4, 2021 20:33 UTC | AMYRIS, INC. AMRS · Entity 91367 | Tax withholdingCommon Stock | 11,526 | $14.56 | $167,818.56 |
DisclosureSEC source: 0001365916-21-000013 · wf-form4_162017478487509.xml · nonDerivative · entry 1 KELSEY NICOLE · CIK 0001714653 · GENERAL COUNSEL AND SECRETARY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,255 F1 · shares: Shares withheld to satisfy the Reporting Person's tax withholding obligation upon vesting of restricted stock units (RSUs) under RSU award granted on May 29, 2018. Read SEC document |
| August 10, 2020 Filed Aug 12, 2020 19:46 UTC | AMYRIS, INC. AMRS · Entity 91367 | GrantWarrant (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $3.86 | $0.00 |
DisclosureSEC source: 0001365916-20-000157 · wf-form4_159727597585802.xml · derivative · entry 2 KELSEY NICOLE · CIK 0001714653 · GENERAL COUNSEL AND SECRETARY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2030-08-10 F2 · derivative.exercise_date: The stock option vests as to 25% of the shares subject to the option on September 1, 2020, with the remainder vesting over the following three (3) years in equal monthly installments. Read SEC document |
| August 10, 2020 Filed Aug 12, 2020 19:46 UTC | AMYRIS, INC. AMRS · Entity 91367 | GrantCommon Stock | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001365916-20-000157 · wf-form4_159727597585802.xml · nonDerivative · entry 1 KELSEY NICOLE · CIK 0001714653 · GENERAL COUNSEL AND SECRETARY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,781 F1 · shares: Represents a restricted stock unit award that vests in three (3) equal installments, with the first 1/3 of the units vesting on September 1, 2020. Read SEC document |
| August 10, 2020 Filed Aug 28, 2020 19:45 UTC Amendment | AMYRIS, INC. AMRS · Entity 91367 | GrantWarrant (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $3.86 | $0.00 |
DisclosureSEC source: 0001365916-20-000174 · wf-form4a_159865832153565.xml · derivative · entry 2 KELSEY NICOLE · CIK 0001714653 · GENERAL COUNSEL AND SECRETARY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2030-08-10 F2 · derivative.exercise_date: The stock option vests as to 25% of the shares subject to the option on September 1, 2021, with the remainder vesting over the following three (3) years in equal monthly installments. Due to an unintentional error, the first vesting date of the stock option was incorrectly listed as September 1, 2020 in the Prior Form 4. Read SEC document |
| August 10, 2020 Filed Aug 28, 2020 19:45 UTC Amendment | AMYRIS, INC. AMRS · Entity 91367 | GrantCommon Stock | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001365916-20-000174 · wf-form4a_159865832153565.xml · nonDerivative · entry 1 KELSEY NICOLE · CIK 0001714653 · GENERAL COUNSEL AND SECRETARY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,781 F1 · shares: Represents a restricted stock unit award that vests in three (3) equal annual installments, with the first 1/3 of the units vesting on September 1, 2021. Due to an unintentional error, the first vesting date of the units was incorrectly listed as September 1, 2020 in the Form 4 filed on August 12, 2020 (the "Prior Form 4"). Read SEC document |
| August 01, 2020 Filed Aug 4, 2020 20:23 UTC | AMYRIS, INC. AMRS · Entity 91367 | Tax withholdingCommon Stock | 2,420 | $4.28 | $10,357.60 |
DisclosureSEC source: 0001365916-20-000124 · wf-form4_159658695418831.xml · nonDerivative · entry 1 KELSEY NICOLE · CIK 0001714653 · GENERAL COUNSEL AND SECRETARY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,781 F1 · shares: Shares withheld to satisfy the Reporting Person's tax withholding obligation upon vesting of restricted stock units (RSUs) under RSU award granted on August 14, 2017. Read SEC document |
| May 01, 2020 Filed May 5, 2020 20:02 UTC | AMYRIS, INC. AMRS · Entity 91367 | Tax withholdingCommon Stock | 11,433 | $2.49 | $28,468.17 |
DisclosureSEC source: 0001365916-20-000062 · edgar.xml · nonDerivative · entry 1 KELSEY NICOLE · CIK 0001714653 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,201 F1 · shares: Shares withheld to satisfy the Reporting Person's tax withholding obligation upon vesting of restricted stock units (RSUs) under RSU award granted on May 29, 2018. Read SEC document |
| August 01, 2019 Filed Aug 5, 2019 20:07 UTC | AMYRIS, INC. AMRS · Entity 91367 | Tax withholdingCommon Stock | 2,420 | $2.93 | $7,090.60 |
DisclosureSEC source: 0001365916-19-000045 · edgar.xml · nonDerivative · entry 1 KELSEY NICOLE · CIK 0001714653 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,634 F1 · shares: Shares withheld to satisfy the Reporting Person's tax withholding obligation upon vesting of restricted stock units (RSUs) under RSU award granted on August 14, 2017. Read SEC document |
| May 01, 2019 Filed May 3, 2019 19:47 UTC | AMYRIS, INC. AMRS · Entity 91367 | Tax withholdingCommon Stock | 11,526 | $4.05 | $46,680.30 |
DisclosureSEC source: 0001365916-19-000021 · edgar.xml · nonDerivative · entry 1 KELSEY NICOLE · CIK 0001714653 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,054 F1 · shares: Shares withheld to satisfy the Reporting Person's tax withholding obligation upon vesting of restricted stock units (RSUs) under RSU award granted on May 29, 2018. Read SEC document |
| August 01, 2018 Filed Sep 25, 2018 20:27 UTC | AMYRIS, INC. AMRS · Entity 91367 | Tax withholdingCommon Stock | 2,420 | $6.96 | $16,843.20 |
DisclosureSEC source: 0001567619-18-003111 · doc1.xml · nonDerivative · entry 1 KELSEY NICOLE · CIK 0001714653 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,580 F1 · shares: Shares withheld to satisfy the Reporting Person's tax withholding obligation upon settlement of restricted stock units (RSUs) under RSU award granted on August 14, 2017. Read SEC document |
| May 29, 2018 Filed May 31, 2018 19:11 UTC | AMYRIS, INC. AMRS · Entity 91367 | GrantStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $5.08 | $0.00 |
DisclosureSEC source: 0001140361-18-026665 · doc1.xml · derivative · entry 2 KELSEY NICOLE · CIK 0001714653 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2028-05-29 F2 · derivative.exercise_date: The stock option vests as to 25% of the shares subject to the option on May 1, 2019 with the remainder vesting over the following three (3) years in thirty-six (36) equal monthly installments. Read SEC document |
| May 29, 2018 Filed May 31, 2018 19:11 UTC | AMYRIS, INC. AMRS · Entity 91367 | GrantCommon Stock | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-18-026665 · doc1.xml · nonDerivative · entry 1 KELSEY NICOLE · CIK 0001714653 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,000 F1 · shares: Represents a restricted stock unit award that vests in three (3) equal annual installments, with the first 1/3rd of the units vesting on May 1, 2019. Read SEC document |
| August 14, 2017 Filed Aug 16, 2017 19:34 UTC | AMYRIS, INC. AMRS · Entity 91367 | GrantStock Option (Right to Buy) · Derivative | 9,000 | $0.00 Strike: $2.49 | $0.00 |
DisclosureSEC source: 0001365916-17-000073 · edgar.xml · derivative · entry 2 KELSEY NICOLE · CIK 0001714653 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,000 Underlying: Common Stock · 9,000 shares Expires 2027-08-14 F2 · derivative.exercise_date: The stock option vests as to 50% of the shares subject to the option upon completion of twelve (12) months of employment, and the remainder vesting over the following three (3) years in thirty-six (36) equal monthly installments upon completion of each additional month of employment. Read SEC document |
| August 14, 2017 Filed Aug 16, 2017 19:34 UTC | AMYRIS, INC. AMRS · Entity 91367 | GrantCommon Stock | 21,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001365916-17-000073 · edgar.xml · nonDerivative · entry 1 KELSEY NICOLE · CIK 0001714653 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,000 F1 · shares: Represents a restricted stock unit award that vests in three (3) equal annual installments, with the first 1/3rd of the units vesting on August 1, 2018. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.